The information highlighted (if any) are the most recent updates for this brand.
Ipratropium bromide + salbutamol (Combivent UDV) is contraindicated in: Patients with hypertrophic obstructive cardiomyopathy or tachyarrhythmia; Patients with known hypersensitivity to atropine or its derivatives or to any other component of the product.